Original article/Article originalOLIGOMYCIN (cas 1404-19-9)s A and E, major bioactive secondary metabolites produced by Streptomyces sp. strain HG29 isolated from a Saharan soil

Add time:09/03/2019    Source:sciencedirect.com

SummaryAn actinobacterial strain, HG29, with potent activity against pathogenic, toxigenic and phytopathogenic fungi was isolated from a Saharan soil sample of Algeria. On the basis of morphological and chemotaxonomic characteristics, the strain was classified in the genus Streptomyces. Analysis of the 16S rRNA gene sequence showed a similarity level of 99.3% with Streptomyces gancidicus NBRC 15412T. The comparison of its cultural and physiological characteristics with this species revealed significant differences. Moreover, the phylogenetic tree showed that strain HG29 forms a distinct phyletic line within the genus Streptomyces. Production of antifungal activity was investigated by following kinetics in shake broth. The highest antifungal activity was obtained after five days of fermentation, and in the dichloromethane extract. Two active compounds, NK1 and NK2, were purified by HPLC using a C18 column. Their chemical structures were identified through nuclear magnetic resonance experiments and mass spectrometry as oligomycins E and A, respectively, which have not been reported to be produced by S. gancidicus. The two bioactive compounds exhibited significant antifungal activity in vitro, showing minimal inhibitory concentrations (MICs) values between 2 and 75 μg/mL.

We also recommend Trading Suppliers and Manufacturers of OLIGOMYCIN (cas 1404-19-9). Pls Click Website Link as below: cas 1404-19-9 suppliers

Prev:Synthesis and cytotoxicity of OLIGOMYCIN (cas 1404-19-9) A derivatives modified in the side chain
Next:Research paperThe mitochondrial F1FO-ATPase desensitization to OLIGOMYCIN (cas 1404-19-9) by tributyltin is due to thiol oxidation)